BPH Resource Center Clinical Briefs

• Formal 1-to-1 Physical Therapy Ineffective to Treat Incontinence After Prostate Surgery
  Medscape Education Clinical Briefs July 12, 2011
  Conservative one-to-one physical therapy for urinary incontinence following prostate surgery was no more effective than standard care with pelvic floor exercises.
  
  Save
• Updated BPH Treatment Guideline Released
  Medscape Education Clinical Briefs February 11, 2011
  The American Urological Association has weighed the efficacy of various benign prostate hyperplasia treatments and updated guidelines previously issued in 2003.
  
  Save
• Management of BPH and Prostate Cancer Reviewed
  Medscape Education Clinical Briefs November 23, 2010
  An overview of benign prostatic hyperplasia and prostate cancer management aimed at primary care physicians notes that watchful waiting or active surveillance are options in selected patients.
  
  Save
• Dihydrotestosterone May Not Affect Prostate Growth But May Reduce BMD
  Medscape Education Clinical Briefs November 16, 2010
  In a study of healthy older men, dihydrotestosterone treatment for 24 months did not affect prostate growth but caused a decrease in spinal, but not hip, bone mineral density.
  
  Save
• Urinary Tract Symptoms Reduced With Long-Term Therapy in Patients With BPH
  Medscape Education Clinical Briefs October 08, 2010
  Based on a systematic review, a 5-alpha-reductase inhibitor vs placebo and active comparators improves long-term urinary tract symptoms associated with benign prostatic hyperplasia.
  
  Save
• FDA Approves Dutasteride/Tamsulosin Combo Pill for BPH
  Medscape Education Clinical Briefs June 22, 2010
  The FDA has approved a single-capsule formulation of 0.5 mg dutasteride and 0.4 mg tamsulosin for symptomatic BPH in men with an enlarged prostate.
  
  Save
• Tamsulosin Use Linked to Serious Ophthalmic Adverse Events After Cataract Surgery
  Medscape Medical News May 19, 2009
  Use of tamsulosin within 14 days of cataract surgery, but not of other alpha-blocker medications used to treat benign prostatic hyperplasia, was significantly associated with serious postoperative ophthalmic adverse events.
  
  Save
• FDA Approvals: Rapaflo and Akten
  Medscape Medical News October 16, 2008
  The FDA has approved silodosin capsules (Rapaflo) and lidocaine HCl 3.5% ophthalmic gel (Akten).
  
  Save
• 5-Alpha Reductase Inhibitors May Not Increase Fracture Risk
  Medscape Medical News October 07, 2008
  In a case-control study, use of 5-alpha reductase inhibitors did not appear to increase the risk for fractures in men with benign prostatic hyperplasia.
  
  Save
• FDA Approvals: Avodart and Trivaris
  Medscape Medical News June 26, 2008
  The FDA has approved a new indication for dutasteride capsules (Avodart) and triamcinolone acetonide injectable suspension (Trivaris).
  
  Save
• Management of Benign Prostatic Hyperplasia Reviewed
  Medscape Medical News May 19, 2008
  A review provides recommendations for diagnosing and treating benign prostatic hyperplasia.
  
  Save
• Diabetes Linked to Irritative Lower Urinary Tract Symptoms, Nocturia
  Medscape Medical News March 21, 2008
  A multiethnic, community-based study shows positive associations between diabetes and irritative lower urinary tract symptoms and nocturia but not benign prostatic hyperplasia.
  
  Save
• Dutasteride/Tamsulosin May Be Helpful for Benign Prostatic Hyperplasia
  Medscape Medical News December 28, 2007
  Two-year results from an ongoing study show that men with moderate to severe lower urinary tract symptoms and prostate enlargement have greater benefit from combination therapy vs monotherapy.
  
  Save
• Starch Intake May Increase Risk for Benign Prostatic Hyperplasia
  Medscape Medical News March 14, 2007
  Further analysis of a case-control study suggests that starch may increase the risk for BPH, whereas polyunsaturated fatty acids may decrease the risk.
  
  Save
• High Vegetable Intake Linked to Lower Risk for BPH
  Medscape Medical News February 20, 2007
  A study showed that men who had a high intake of vegetables, particularly those rich in beta-carotene, had a reduced risk for benign prostatic hyperplasia.
  
  Save
• Alpha-Blockers May Not Improve Symptoms of Nocturia Linked With BPH
  Medscape Medical News July 05, 2006
  A study suggests that the duration of benign prostatic hyperplasia and water intake before bed are associated with nocturia symptoms.
  
  Save
• FDA Safety Changes: Paxil, Paxil CR, Cardura, Zyprexa
  Medscape Medical News May 31, 2006
  The FDA has approved safety labeling revisions for paroxetine, doxazosin, and olanzapine.
  
  Save
• Elevated Plasma Glucose, Diabetes, Obesity May Increase Risk...
  Medscape Medical News April 20, 2006
  In a cross-sectional analysis, elevated plasma glucose, diabetes, and obesity were all risk factors for benign prostatic hyperplasia.
  
  Save
• Saw Palmetto May Be of No Benefit in the Treatment of BPH
  Medscape Medical News February 08, 2006
  Based on this randomized study, the editorialist reminded us that it is the responsibility of clinicians to inform and protect their patients from unproven therapies.
  
  Save
• Dietary Factors May Affect Risk for Benign Prostatic Hyperplasia
  Medscape Medical News February 07, 2006
  In an Italian population, a diet rich in cereals and some types of meat and poor in vegetables and green peas, beans, and lentils had an unfavorable effect.
  
  Save